Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The citric acid cycle enzyme system, also known as the Krebs cycle or tricarboxylic acid (TCA) cycle, is a series of enzyme-catalyzed biochemical reactions that occur in the mitochondrial matrix of eukaryotic cells. This system is central to cellular metabolism, serving as the final common pathway for the oxidative catabolism of carbohydrates, fatty acids, and amino acids. The primary function is to oxidize acetyl-CoA to carbon dioxide (CO₂), while reducing coenzymes NAD⁺ and FAD to NADH and FADH₂. These reduced coenzymes then feed electrons into the electron transport chain for ATP production. Intermediates serve as precursors for biosynthesis of amino acids, nucleotides, heme groups, etc. Defects or deficiencies in any component enzyme can lead to metabolic disorders with wide-ranging effects due to impaired energy production.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Citric Acid Cycle Enzyme System (TCA Cycle).